COVID-19 Infection among Elite Football Players: A Nationwide Prospective Cohort Study
Abstract
:1. Introduction
2. Materials and Method
2.1. Laboratory Testing
2.2. History Taking and Physical Examinations
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Buitrago-Garcia, D.; Egli-Gany, D.; Counotte, M.J.; Hossmann, S.; Imeri, H.; Ipekci, A.M.; Salanti, G.; Low, N. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020, 17, e1003346. [Google Scholar] [CrossRef]
- Oran, A.D.P.; Topol, E.J. The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review. Ann. Intern. Med. 2021, 174, 655–662. [Google Scholar] [CrossRef] [PubMed]
- Ma, Q.; Liu, J.; Liu, Q.; Kang, L.; Liu, R.; Jing, W.; Wu, Y.; Liu, M. Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: A systematic review and meta-analysis. JAMA Netw. Open 2021, 4, e2137257. [Google Scholar] [CrossRef] [PubMed]
- Uefa Annual Report 2019/20 Contents. Available online: https://editorial.uefa.com/resources/0268-1215a1e8bf40-512630baee20-1000/uefa_annual_report_2019-20.pdf (accessed on 10 February 2022).
- World Health Organization. Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases; World Health Organization: Geneva, Switzerland, 2020; pp. 1–7. Available online: https://apps.who.int/iris/bitstream/handle/10665/331501/WHOCOVID-19-laboratory-2020.5eng.pdf (accessed on 8 April 2022).
- Krzywański, J.; Mikulski, T.; Krysztofiak, H.; Pokrywka, A.; Młyńczak, M.; Małek, Ł.A.; Kwiatkowska, D.; Kuchar, E. Elite athletes with COVID-19—Predictors of the course of dis-ease. J. Sci. Med. Sport 2022, 25, 9–14. [Google Scholar] [CrossRef]
- da Silva, F.B.; Fonseca, B.; Domecg, F.; Facio, M.R.; Prado, C.; Toledo, L.; Tuche, W. Athletes health during pandemic times: Hospitalization rates and variables related to COVID-19 Prevalence among Endurance Athletes. Int. J. Cardiovasc. Sci. 2021, 34, 274–283. [Google Scholar] [CrossRef]
- Egger, F.; Faude, O.; Schreiber, S.; Gärtner, B.C.; Meyer, T. Does playing football (soccer) lead to SARS-CoV-2 transmission?—A case study of 3 matches with 18 infected football players. Sci. Med. Footb. 2021, 5 (Suppl. S1), 2–7. [Google Scholar] [CrossRef]
- Schreiber, S.; Faude, O.; Gärtner, B.; Meyer, T.; Egger, F. Risk of SARS-CoV-2 transmission from on-field player contacts in amateur, youth and professional football (soccer). Br. J. Sports Med. 2022, 56, 158–164. [Google Scholar] [CrossRef]
- Pedersen, L.; Lindberg, J.; Lind, R.R.; Rasmusen, H. Reopening elite sport during the COVID-19 pandemic: Experiences from a controlled return to elite football in Denmark. Scand. J. Med. Sci. Sports 2021, 31, 936–939. [Google Scholar] [CrossRef]
- Meyer, T.; Mack, D.; Donde, K.; Harzer, O.; Krutsch, W.; Rössler, A.; Kimpel, J.; von Laer, D.; Gärtner, B.C. Successful return to professional men’s football (soccer) competition after the COVID-19 shutdown: A cohort study in the German Bundesliga. Br. J. Sports Med. 2021, 55, 62–66. [Google Scholar] [CrossRef]
- World Health Organization (WHO). Coronavirus Disease (COVID-19) Technical Guidance: Laboratory Testing for 2019-nCoV in Humans. 2020. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidanc (accessed on 15 December 2021).
- Clopper, C.; Pearson, E. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934, 26, 404–413. [Google Scholar] [CrossRef]
- Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br. Med. J. Clin. Res. Ed. 1988, 296, 1313–1316. [CrossRef] [PubMed] [Green Version]
- Altman, D.G.; Bland, J.M. How to obtain the confidence interval from a p value? BMJ 2011, 343, d2090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- StataCorp. Stata Statistical Software: Release 17; StataCorp LLC: College Station, TX, USA, 2021. [Google Scholar]
- Schumacher, Y.O.; Tabben, M.; Hassoun, K.; Al Marwani, A.; Al Hussein, I.; Coyle, P.; Abbassi, A.K.; Ballan, H.T.; Al-Kuwari, A.; Chamari, K.; et al. Resuming professional football (soccer) during the COVID-19 pandemic in a country with high infection rates: A prospective cohort study. Br. J. Sports Med. 2021, 55, 1092–1098. [Google Scholar] [CrossRef] [PubMed]
- Gianfredi, V.; Mauer, N.S.; Gentile, L.; Riccò, M.; Odone, A.; Signorelli, C. COVID-19 and Recreational Skiing: Results of a Rapid Systematic Review and Possible Preventive Measures. Int. J. Environ. Res. Public Health 2021, 18, 4349. [Google Scholar] [CrossRef]
- Jones, B.; Phillips, G.; Kemp, S.; Payne, B.; Hart, B.; Cross, M.; Stokes, K.A. SARS-CoV-2 transmission during rugby league matches: Do players become infected after participating with SARS-CoV-2 positive players? Br. J. Sports Med. 2021, 55, 807–813. [Google Scholar] [CrossRef]
- Zhu, Z.; Lian, X.; Su, X.; Wu, W.; Marraro, G.A.; Zeng, Y. From SARS and MERS to COVID-19: A brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human corona viruses. Respir. Res. 2020, 21, 224. [Google Scholar] [CrossRef]
- Oran, D.P.; Topol, E.J. Prevalence of asymptomatic SARS-CoV-2 infection: A narrative review. Ann. Intern. Med. 2020, 173, 362–367. [Google Scholar] [CrossRef]
- Poole, S.F.; Gronsbell, J.; Winter, D.; Nickels, S.; Levy, R.; Fu, B.; Burq, M.; Saeb, S.; Edwards, M.D.; Behr, M.K.; et al. A holistic approach for suppression of COVID-19 spread in workplaces and universities. PLoS ONE 2021, 16, e0254798. [Google Scholar] [CrossRef]
- Gallè, F.; Sabella, E.A.; Roma, P.; Da Molin, G.; Diella, G.; Montagna, M.T.; Ferracuti, S.; Liguori, G.; Orsi, G.B.; Napoli, C. Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy. Vaccines 2021, 9, 1222. [Google Scholar] [CrossRef]
- Signorelli, C.; Odone, A.; Miduri, A.; Cella, P.; Pasquarella, C.; Gozzini, A.; Tamburrino, P.; Castellacci, E. Flu vaccination in elite athletes: A survey among Serie A soccer teams. Acta Biomed. 2016, 87, 117–120. [Google Scholar]
- Papagiannis, D.; Rachiotis, G.; Xanthopoulos, A.; Simou, A.; Zilidis, C.; Triposkiadis, F. Vaccination practices and influenza in professional football players in Greece. Occup. Med. 2020, 70, 200–202. [Google Scholar] [CrossRef] [PubMed]
Athletes | Staff Members | ||
---|---|---|---|
Test result | Positive | 130 (0.57%) | 60 (0.27%) |
Negative | 22,509 (99.43%) | 22,466 (99.73%) | |
Total | 22,639 | 22,526 | |
1 (95% CI) = 0.57% (0.48%, 0.68%) 2 (95% CI) = 0.27% (0.20%, 0.34%) 3 [(95% CI), p-value] = 2.16 4 [(1.59, 2.93), <0.001] |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Papagiannis, D.; Laios, T.; Tryposkiadis, K.; Kouriotis, K.; Roussis, X.; Basdekis, G.; Boudouris, P.; Cholevas, C.; Karakitsios, S.; Kakavas, P.; et al. COVID-19 Infection among Elite Football Players: A Nationwide Prospective Cohort Study. Vaccines 2022, 10, 634. https://doi.org/10.3390/vaccines10050634
Papagiannis D, Laios T, Tryposkiadis K, Kouriotis K, Roussis X, Basdekis G, Boudouris P, Cholevas C, Karakitsios S, Kakavas P, et al. COVID-19 Infection among Elite Football Players: A Nationwide Prospective Cohort Study. Vaccines. 2022; 10(5):634. https://doi.org/10.3390/vaccines10050634
Chicago/Turabian StylePapagiannis, Dimitrios, Theodoros Laios, Konstantinos Tryposkiadis, Konstantinos Kouriotis, Xenophon Roussis, Georgios Basdekis, Panagiotis Boudouris, Christos Cholevas, Stergios Karakitsios, Pindaros Kakavas, and et al. 2022. "COVID-19 Infection among Elite Football Players: A Nationwide Prospective Cohort Study" Vaccines 10, no. 5: 634. https://doi.org/10.3390/vaccines10050634
APA StylePapagiannis, D., Laios, T., Tryposkiadis, K., Kouriotis, K., Roussis, X., Basdekis, G., Boudouris, P., Cholevas, C., Karakitsios, S., Kakavas, P., Kiriakidis, T., Kouloumentas, P., Kouvidis, G., Manoudis, G., Nikolaou, P., Theos, C., Piskopakis, A. -N., Rallis, I., Ristanis, S., ... Rachiotis, G. (2022). COVID-19 Infection among Elite Football Players: A Nationwide Prospective Cohort Study. Vaccines, 10(5), 634. https://doi.org/10.3390/vaccines10050634